| Cat. No. |
Products |
Formula |
CAS＃ |
Specification |
Purity |
Package |
| MC |
Carbohydrates |
|
|
|
|
|
| MC001 |
1,2:3,5-Di-O-isopropylidene-a-
D-xylofuranose |
C11H18O5 |
20881-04-3 |
|
98.0% min. |
|
| MC002 |
1,2:5,6-Di-O-isopropylidene-3-O-(methyl-sulfonyl)-a-D-glucofuranose |
C13H22O8S |
5450-26-0 |
|
98.0% min. |
|
| MC003 |
1,2:5,6-Di-O-isopropylidene-Alpha-D-Allofuranose |
C12H20O6 |
2595-05-3 |
|
98.0% min. |
|
| MC004 |
1,2:5,6-di-o-isopropylidene-Mannitol |
C12H20O6 |
1707-77-3 |
|
98.0% min. |
|
| MC005 |
1,2-O-Iso-propylidene-D-Glucofuranose |
C9H16O6 |
18549-40-1 |
|
98.0% min. |
|
| MC006 |
2,3,4,6-Tetra-O-Acetyl-a-D-Galactopyranosyl-Bromide |
C14H19BrO9 |
3068-32-4 |
|
95.0% min. |
|
| MC007 |
2,3,5-tri-O-Benzyl-1-O-(4-nitrobenzoyl)-Arabinofuranose |
C33H31NO8 |
52522-49-3 |
|
98.0% min. |
|
| MC008 |
2-Deoxyl-D-glucose |
C6H12O5 |
154-17-6 |
|
99.0% min. |
|
| MC009 |
4-Methylumbelliferyl-β-D-glucuronic acid
dihydrate (MUG) |
C10H16O9.2H2O |
6160-80-1 |
|
98.0% min. |
|
| MC010 |
Alpha-Cellobiose
Octaacetate |
C9H16O6 |
5346-90-7 |
|
98.0% min. |
|
| MC011 |
Alpha-D-Glucose
Pentaacetate |
C16H22O11 |
604-68-2 |
|
98.0% min. |
|
| MC012 |
Beta-D-Glucose
Pentaacetate |
C16H22O12 |
604-69-3 |
|
98.0% min. |
|
| MC013 |
Beta-D-Ribofuranose
1,2,3,5-tetraacetate |
C13H18O9 |
13035-61-5 |
|
98.0% min. |
|
| MC014 |
D-(-)-Arabinose |
C5H10O5 |
28697-53-2 |
|
99.0% min. |
|
| MC015 |
D-(-)-Gulonic
acid-gamma-Lactone |
C6H10O6 |
6322-07-2 |
|
99.0% min. |
|
| MC016 |
D-(-)-Ribose |
C5H10O5 |
50-69-1 |
|
99.5% min. |
|
| MC017 |
D-(+)-Cellobiose |
C12H22O11 |
528-50-7 |
|
98.0% min. |
|
| MC018 |
D-(+)-Galactosamine
HCl |
C6H13NO5.HCl |
1772-03-8 |
|
99.0% min. |
|
| MC019 |
D-(+)-Galactose |
C6H12O6 |
59-23-4 |
|
99.0% min. |
|
| MC020 |
Diacetone-D-glucose |
C12H20O6 |
582-52-5 |
|
98.0% min. |
|
| MC021 |
D-Mannosamine HCl |
C6H13NO5.HCl |
5505-63-5 |
|
98.0% min. |
|
| MC022 |
Dulcitol; Galactitol |
C6H14O6 |
608-66-2 |
|
99.0% min. |
|
| MC023 |
L(+)-Arabinose |
C5H10O5 |
87-72-9 |
|
99.0% min. |
|
| MC024 |
L(+)-Ribose |
C5H10O5 |
24259-59-4 |
|
99.0% min. |
|
| MC025 |
Lactobionic acid |
C12H22O12 |
96-82-2 |
|
97.0% min. |
|
| MC026 |
L-Mannono-1,4-Lactone |
C6H10O6 |
22430-23-5 |
|
99.0% min. |
|
| MC027 |
N-Acetyl-D-Mannosamine |
C8H15NO6 |
7772-94-3 |
|
98.0% min. |
|
| |
|
|
|
|
|
|
| MS |
Steroids |
|
|
|
|
|
| MS001 |
Allylestrenol |
C21H32O |
432-60-0 |
|
99.0% min. |
|
| MS002 |
Desogestrel |
C22H30O |
54024-22-5 |
|
99.0% min. |
|
| MS003 |
Lynestrenol |
C20H28O |
52-76-6 |
|
99.0% min. |
|
| MS004 |
Nilestriol |
C25H32O3 |
39791-20-3 |
|
99.0% min. |
|
| MS005 |
Stigmasterol |
C29H48O |
83-48-7 |
|
95.0% min. |
|
| |
|
|
|
|
|
|
| MP |
Pharmaceuticals |
|
|
|
|
|
| MP001 |
Benzocaine |
C9H11NO2 |
94-09-7 |
|
99.0% min. |
|
| MP002 |
Cinepazide |
C22H31N3O5 |
23887-46-9 |
|
99.0% min. |
|
| MP003 |
D-a-Lipoic acid |
C8H14O2S2 |
1200-22-2 |
|
99.0% min. |
|
| MP004 |
Levalbuterol (Levo
albutamol) |
C13H21NO3 |
34391-04-3 |
|
99.0% min. |
|
| MP005 |
Levobupivacaine |
C18H2N2O |
27262-47-1 |
|
99.0% min. |
|
| MP006 |
Levocetirizine |
C21H25ClN2O3 |
130018-77-8 |
|
99.0% min. |
|
| MP007 |
Levosimendan |
C14H12NO6 |
141505-33-1 |
|
99.0% min. |
|
| MP008 |
Levothyroxine |
C15H11I4NO4 |
51-48-9 |
USP |
|
|
| MP009 |
Levothyroxine Sodium |
C15H10I4NO4Na |
55-03-8 |
USP |
|
|
| MP010 |
Nicomol |
C34H32N4O9 |
27959-26-8 |
|
99.0% min. |
|
| MP011 |
Nifekalant |
C19H27N5O5 |
130636-43-0 |
|
99.0% min. |
|
| MP012 |
Tetracaine Base |
C15H26N2O2 |
94-24-6 |
|
99.0% min. |
|
| MP013 |
Tetracaine HCl |
C15H26N2O2.HCl |
136-47-0 |
|
99.0% min. |
|
| MP014 |
(s)-Zopiclone |
C17H17ClN6O3 |
138729-47-2 |
|
99.0% min. |
|
| |
|
|
|
|
|
|
| MM |
Miscellaneous |
|
|
|
|
|
| MM001 |
Octocrylene |
C24H27O2N |
6197-30-4 |
|
98.0% min. |
|
| MM002 |
Phytanetriol |
C20H42O3 |
94563-64-7 |
|
98.0% min. |
|
| MM003 |
Flunixn Meglumine |
C14H11O2NF3.C7H15O5N |
38677-95-9 |
USP |
|
|
| MM006 |
Lynoestrenol |
C20H28O |
52-76-6 |
|
99.0%
min. |
|
|
|
|
|
|
|
| MM007 |
prilocaine |
C13H20N2O |
1786-81-8 |
|
98%
min. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|